• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification as a clinical manifestation of bone-vascular axis].

作者信息

Yamamoto Masahiro

机构信息

Internal Medicine 1, Shimane University Faculty of Medicine, Japan.

出版信息

Clin Calcium. 2015 May;25(5):655-60.

PMID:25926568
Abstract

Several clinical studies has been shown the close relationship between osteoporosis and arteriosclerosis, and basic researches confirmed the reasonability of this association by the findings that organized molecular mechanism of bone formation in bone tissue was also observed in the lesion of vascular calcification, RANK/RANKL/OPG axis is one of potent and explainable molecular mechanism for bone-vascular association. However, one recent clinical intervetion study using RANKL antibody for post menopauisal women with primary osteoporosis could not validate that relationship. Further examinations are needed to improve understanding of the precise mechanism in this area.

摘要

相似文献

1
[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification as a clinical manifestation of bone-vascular axis].
Clin Calcium. 2015 May;25(5):655-60.
2
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.骨保护素/RANK/RANKL 系统:血管疾病的关键之骨。
J Endocrinol Invest. 2009;32(4 Suppl):6-9.
3
CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.临床综述#:核因子κB受体激活剂(RANK)/RANK配体/骨保护素的作用:临床意义
J Clin Endocrinol Metab. 2007 Dec;92(12):4514-21. doi: 10.1210/jc.2007-0646. Epub 2007 Sep 25.
4
Role of OPG/RANKL/RANK axis on the vasculature.骨保护素/核因子κB受体活化因子配体/核因子κB受体活化因子轴在脉管系统中的作用。
Histol Histopathol. 2008 Apr;23(4):497-506. doi: 10.14670/HH-23.497.
5
RANKL/RANK - from bone physiology to breast cancer.RANKL/RANK-从骨生理学到乳腺癌。
Cytokine Growth Factor Rev. 2014 Apr;25(2):205-14. doi: 10.1016/j.cytogfr.2014.01.002. Epub 2014 Jan 10.
6
[Biomarkers of vascular calcifications: the osteoprotegerin/RANK/RANK L axis].
Ann Biol Clin (Paris). 2015 May-Jun;73(3):289-98. doi: 10.1684/abc.2015.1051.
7
RANK/RANKL/OPG role in distraction osteogenesis.RANK/RANKL/OPG在牵张成骨中的作用。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):679-86. doi: 10.1016/j.tripleo.2009.10.042. Epub 2010 Feb 16.
8
Key roles of the OPG-RANK-RANKL system in bone oncology.OPG-RANK-RANKL系统在骨肿瘤学中的关键作用。
Expert Rev Anticancer Ther. 2007 Feb;7(2):221-32. doi: 10.1586/14737140.7.2.221.
9
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.破骨细胞调节因子RANKL和骨保护素对血管钙化的调节作用
Circ Res. 2004 Nov 26;95(11):1046-57. doi: 10.1161/01.RES.0000149165.99974.12.
10
[Osteoporosis and aterosclerosis--is there any pathogenetic association?].[骨质疏松症与动脉粥样硬化——是否存在发病机制上的关联?]
Cas Lek Cesk. 2007;146(3):246-50.

引用本文的文献

1
Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/β-catenin pathway.Klotho/FGF23 轴通过 Wnt7b/β-连环蛋白通路介导高磷诱导的血管平滑肌细胞血管钙化。
Kaohsiung J Med Sci. 2019 Jul;35(7):393-400. doi: 10.1002/kjm2.12072. Epub 2019 Apr 18.